title: Immune mediated diseases and immune modulation in the neurocritical care unit.
abstract: This chapter will review the spectrum of immune-mediated diseases that affect the nervous system and may result in an admission to the neurological intensive care unit. Immunomodulatory strategies to treat acute exacerbations of neurological diseases caused by aberrant immune responses are discussed, but strategies for long-term immunosuppression are not presented. The recommendations for therapeutic intervention are based on a synthesis of the literature, and include recommendations by the Cochrane Collaborative, the American Academy of Neurology, and other key organizations. References from recent publications are provided for the disorders and therapies in which randomized clinical trials and large evidenced-based reviews do not exist. The chapter concludes with a brief review of the mechanisms of action, dosing, and side effects of commonly used immunosuppressive strategies in the neurocritical care unit.
authors.affiliation: Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD 21287, USA.
authors.forename: Gloria
authors.initials: G
authors.lastname: von Geldern
authors.forename: Thomas
authors.initials: T
authors.lastname: McPharlin
authors.forename: Kyra
authors.initials: K
authors.lastname: Becker
mesh_terms: D020274:Autoimmune Diseases of the Nervous System / Q000276:immunology* / Q000628:therapy*; D003422:Critical Care / Q000379:methods*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007155:Immunologic Factors / Q000627:therapeutic use*; D056747:Immunomodulation; D010956:Plasmapheresis / Q000379:methods
chemical_list: D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors